WESTBOROUGH, MA--(Marketwire - July 13, 2009) - IBC Life Sciences announced today that it will offer a total of 10 complimentary registrations and poster board spaces to qualified students in Massachusetts working toward careers in drug discovery and development-related disciplines. The recipients will be selected by the conference organizers/advisors and each student chosen will present their poster in the Drug Discovery & Development poster hall and receive complimentary registration for the conference under which they submitted their poster abstract.
Submissions will be accepted in the following five conference areas:
-- The Next Wave of Antibody Therapeutics -- Oligonucleotide Therapeutics - From Concept to Implementation -- New Frontiers in Cancer Drug Development -- Targets in Context - Linking Targets to Diseases -- Drug Safety Strategies to De-Risk Compounds
Eligible participants must be a full-time graduate student at a university or academic research institute or a Post-doctoral researcher.
Student poster abstracts must be submitted online at the address below no later than Friday, July 17, 2009: http://www.drugdisc.com/xtranav.asp?page=student
Winners of the complimentary registration will receive notification by Friday, July 24th; however all student submissions will qualify for a discount to attend the meeting.
Drug Discovery & Development Week will be held August 3-6 at the World Trade Center Boston & Seaport Hotel in Massachusetts. It includes five targeted scientific conferences that each feature strategies and forward-looking approaches designed to help attendees accelerate small molecules, antibody therapeutics and oligonucleotide therapeutics from early discovery to the clinic. An exhibit and poster hall will showcase cutting-edge technologies and innovative solutions to help facilitate better decisions and to support scientific discoveries. Visit www.drugdisc.com for more information.
About IBC Life Sciences
IBC Life Sciences is the worldwide leader in scientific, technological and business conferences and courses for the life science industry. To develop its programs IBC actively researches the advancements, technologies and trends impacting and driving the race for new drugs and therapies. For more information, visit www.IBCLifeSciences.com.
Contact:
Keri Dostie
(508) 614-1404
Email Contact